The Dr. Francavilla Show

Wegovy, Zepbound, and Foundayo Coverage for Medicare Patients with the Bridge Program


Listen Later

Claim your complimentary gift of my exclusive mini weight care guide today!

Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.com)

What if Medicare finally made GLP-1 medications for weight management more affordable — could this be the moment that changes access for millions of people?

Today, we're talking about something that's been years in the making in the world of obesity care: the expanded coverage of anti-obesity medications for patients on Medicare. Starting July 1st, eligible Medicare beneficiaries have a real opportunity to access GLP-1 receptor agonist medications at a much more affordable monthly cost through a new federal program — and for many patients, this could mark a major shift in access to treatment that's historically been limited or completely out of reach under Medicare's coverage rules.

This change didn't happen overnight. It comes after years of advocacy, policy discussions, and ongoing efforts to get obesity recognized as a chronic medical condition that deserves treatment just like any other disease. In this episode, we break down where this program came from, how it connects to the bigger picture of obesity care, who it applies to, and everything you need to know about eligibility, covered medications, and how the process actually plays out in real life.

Topics discussed:

  • How the Bridge Program Could Expand Access to Obesity Medications
  • For the First Time, Medicare Is Opening the Door to Obesity Medications
  • The BMI and Health Condition Criteria
  • Why the Reason for Your Prescription Matters Just as Much
  • The Details That Make a Real Difference — Prior BMI and Lifestyle Support
  • The List of Weight Loss Medications Covered by the Bridge Program

Want the full breakdown? This episode covers all the details on eligibility, covered medications, and what this program could mean for you or someone you love navigating Medicare and obesity treatment. Find it wherever you get your podcasts — and if it helps, share it with someone who might need to hear it too.

Resources mentioned in this episode:

  • GLP-1 Prescribers Guide — CMS
  • Medicare GLP-1 Bridge Program Details — CMS


Connect with me:

  • Instagram: doctorfrancavilla
  • Facebook: Help Your Patients Lose Weight with Dr. Francavilla
  • Website: Dr. Francavilla Show
  • Youtube: The Doctor Francavilla Show
  • GLP Strong: glpstrong.com
...more
View all episodesView all episodes
Download on the App Store

The Dr. Francavilla ShowBy Dr. Francavilla

  • 4.9
  • 4.9
  • 4.9
  • 4.9
  • 4.9

4.9

69 ratings


More shows like The Dr. Francavilla Show

View all
Biceps After Babies Radio by Amber Brueseke

Biceps After Babies Radio

2,110 Listeners

The Hormone Solution | Menopause, Perimenopause, & Women's Midlife Health by Karen Martel: Certified Hormone Specialist

The Hormone Solution | Menopause, Perimenopause, & Women's Midlife Health

336 Listeners

The Holistic GLP-1 Podcast with Elizabeth McGann by Elizabeth McGann

The Holistic GLP-1 Podcast with Elizabeth McGann

67 Listeners

The Dr. Tyna Show by Dr. Tyna Moore

The Dr. Tyna Show

1,680 Listeners

Docs Who Lift by Docs Who Lift

Docs Who Lift

425 Listeners

The Obesity Guide with Matthea Rentea MD by Matthea Rentea MD

The Obesity Guide with Matthea Rentea MD

264 Listeners

The Plus SideZ: A GLP-1 Guide to Metabolic Health by Kim Carlos

The Plus SideZ: A GLP-1 Guide to Metabolic Health

230 Listeners

On The Pen GLP-1 News by Dave Knapp GLP-1 Industry Insider

On The Pen GLP-1 News

369 Listeners

The Peptide Podcast by The Peptide Queen

The Peptide Podcast

119 Listeners

Fat Science by Dr Emily Cooper

Fat Science

162 Listeners

Conquer Your Weight by Sarah Stombaugh, MD

Conquer Your Weight

45 Listeners

GLP-1 Hub: Support, Community, and Weight Loss by Ana Reisdorf, MS, RD

GLP-1 Hub: Support, Community, and Weight Loss

178 Listeners

GLP-1 Tribe by Eric Eden

GLP-1 Tribe

42 Listeners

Today's discussion by Infinity Peptides

Today's discussion

22 Listeners